also known indazolebased synthetic cannabinoid used active ingredient synthetic cannabis products first identified japan early although little pharmacological information analogue instead reported potent agonist receptor ki intoxication caused one fatality another ketoacidosis combination abchminaca abfubinaca another fatality combination abchminaca united states schedule controlled anlage ii controlled substance germany may swedens public health agency suggested classifying hazardous substance november state louisiana banned emergency rule detected synthetic cannabinoids product called kali berry june controlled fifth schedule misuse drugs act mda singapore may also scheduled japan july october controlled substance december unodc announced scheduling recommendations placing schedule ii controlled research